Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
RAPT Therapeutics is a biopharmaceutical company focused on discovering and developing immunology-based therapies for inflammatory and immunological diseases. Its core pipeline includes monoclonal antibodies and small molecules targeting IgE and CCR4 pathways, aiming to treat allergies, CSU, asthma, and cancers like NSCLC. The company leverages strategic licensing and collaborations to advance innovative treatments with potential competitive advantages in efficacy, safety, and dosing.
This description was generated via AI from an annual report. Updated about 1 year ago.